Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways
Authors:
- Jens U. MarquardtJMJens U. Marquardt
- Chiara RaggiCRChiara Raggi
- Jesper B. AndersenJAJesper B. Andersen
- Daekwan SeoDSDaekwan Seo
- Itzhak AvitalIAItzhak Avital
- David GellerDavid Geller
- Yun-Han LeeYLYun-Han Lee
- Mitsuteru KitadeMKMitsuteru Kitade
- Agnes HolczbauerAHAgnes Holczbauer
- Elizabeth A. ConnerECElizabeth A. Conner
- Valentina M. FactorVFValentina M. Factor
Open Access
- 26 May 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 54 (3) , 1031-1042
Abstract
Epigenetic mechanisms play critical roles in stem cell biology by maintaining pluripotency of stem cells and promoting differentiation of more mature derivatives. If similar mechanisms are relevant for the cancer stem cell (CSC) model, then epigenetic modulation might enrich the CSC population, thereby facilitating CSC isolation and rigorous evaluation. To test this hypothesis, primary human cancer cells and liver cancer cell lines were treated with zebularine (ZEB), a potent DNA methyltransferase-1 inhibitor, and putative CSCs were isolated using the side population (SP) approach. The CSC properties of ZEB-treated and untreated subpopulations were tested using standard in vitro and in vivo assays. Whole transcriptome profiling of isolated CSCs was performed to generate CSC signatures. Clinical relevance of the CSC signatures was evaluated in diverse primary human cancers. Epigenetic modulation increased frequency of cells with CSC properties in the SP fraction isolated from human cancer cells as judged by self-renewal, superior tumor-initiating capacity in serial transplantations, and direct cell tracking experiments. Integrative transcriptome analysis revealed common traits enriched for stemness-associated genes, although each individual CSC gene expression signature exhibited activation of different oncogenic pathways (e.g., EGFR , SRC, and MYC). The common CSC signature was associated with malignant progression, which is enriched in poorly differentiated tumors, and was highly predictive of prognosis in liver and other cancers. Conclusion: Epigenetic modulation may provide a tool for prospective isolation and in-depth analysis of CSC. The liver CSC gene signatures are defined by a pernicious interaction of unique oncogene-specific and common stemness traits. These data should facilitate the identifications of therapeutic tools targeting both unique and common features of CSCs. (HEPATOLOGY 2011;)Keywords
This publication has 39 references indexed in Scilit:
- Tumor Oncogenotypes and Lung Cancer Stem Cell IdentityCell Stem Cell, 2010
- Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating CellsCell Stem Cell, 2010
- Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box FactorsCell Stem Cell, 2009
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem CellsCell Stem Cell, 2008
- The Epigenomics of CancerCell, 2007
- Nuclear factor-κB in cancer development and progressionNature, 2006
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987